New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Using Telemedicine to Bring Genetic Counseling to Community Cancer Care Penn Medicine News News | May 2018 Kravis, Ackman, and Gray Have Some Advice for New Philanthropists Bloomberg News | April 2018 PARP Drugs Help Some Breast Cancer Patients, But They’re No Magic Bullet Forbes News | April 2018 PARP-1 May be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image It Penn Medicine News News | April 2018 At-Home Genetic Testing May Be Convenient, but it Isn't Complete STAT News News | March 2018 FDA Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats New York Times News | March 2018 Genetic Study Makes Testing More Accessible Jewish Exponent News | March 2018 Many Women Mistake Common Symptom of Ovarian Cancer for Indigestion Healthline News | March 2018 Relearning How to Date After My Double Mastectomy The Cut News | March 2018 The Role of Biomarkers in Patients with Breast Cancer Targeted Oncology News | March 2018 Think Before Trying Home Breast Cancer Gene Tests, Experts Urge USA Today News | March 2018 When it Comes to Home Cancer Tests, Think Before You Spit USA Today News | March 2018 BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018 Faith, Fate, and Families Penn Medicine Magazine News | February 2018 Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018 Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018 Individual Knowledge Is Power in Addressing BRCA Gene Mutations Cure Magazine News | January 2018 Phil Basser Celebrates 100 Years with the Eagles Fox News News | January 2018 Pagination First page« First Previous page‹‹ … Page9 Page10 Page11 Page12 Page13 Page14 Current page15 Page16 Page17 Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
Using Telemedicine to Bring Genetic Counseling to Community Cancer Care Penn Medicine News News | May 2018
PARP-1 May be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image It Penn Medicine News News | April 2018
FDA Approves First Home Testing for 3 Breast Cancer Mutations, With Caveats New York Times News | March 2018
BRCA Breast Cancer Patients Finally Have a Non-Chemotherapy Treatment Option Genome News | February 2018
Breast Cancer Caused by Genetic Mutation Gets First Approved Treatment Through FDA Approval of Olaparib Philadelphia Inquirer News | January 2018
Expert Discusses Promise of Olaparib/Durvalumab Combo in BRCA+ Breast Cancer Targeted Oncology News | January 2018
